We carried out immunohistochemical analysis of ezrin and phospho-ezrin (T567) in patient samples of papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC), follicular variant of papillary thyroid carcinoma (FVPTC) and follicular adenoma (FA). This evidence concerns the gene EZR and thyroid cancer, nonmedullary, 2.